Sign in to view content

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch

Estephania Feria, MD

Video
Published 2019

Related

Diabetic Retinopathy 1 Symposium
Annual Meeting Talks
2020
Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study
Mark R. Barakat, MD
Annual Meeting Talks
2021
Diabetic Retinopathy 3 Symposium
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more